StockComparison Logo
vs

BCAX vs VRDN

Comparison between Bicara Therapeutics Inc (BCAX, Company) and Viridian Therapeutics Inc (VRDN, Company).

Both BCAX and VRDN are from the Healthcare sector.

BCAX vs VRDN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
BCAX
$1.89B
VRDN
$1.89B
Max Drawdown
Winner
BCAX
67.82%
VRDN
99.73%
Sharpe Ratio
Winner
BCAX
2.08
VRDN
0.73
5Y Beta
BCAX
1.40
Winner
VRDN
1.10
Industry
BCAX
Biotechnology
VRDN
Biotechnology
P/E Ratio
Winner
BCAX
-10.77
VRDN
-4.79
Forward P/E
BCAX
N/A
VRDN
1.01
5Y EPS CAGR
BCAX
N/A
VRDN
-32.36%
Debt to Equity
BCAX
0.00%
VRDN
0.00%
Free Cash Flow Yield
Winner
BCAX
-6.15%
VRDN
-16.05%
P/S Ratio
BCAX
N/A
VRDN
28.78
P/B Ratio
Winner
BCAX
3.70
VRDN
4.05

BCAX vs VRDN - Historical Returns

Returns include dividend reinvestment.

1M
Winner
BCAX
+47.66%
VRDN
+22.24%
3M
Winner
BCAX
+35.07%
VRDN
+2.97%
6M
Winner
BCAX
+77.05%
VRDN
-36.77%
1Y
Winner
BCAX
+215.22%
VRDN
+27.38%
5Y(CAGR)
BCAX
N/A
VRDN
+1.87%
10Y(CAGR)
BCAX
N/A
VRDN
-14.64%
Max(CAGR)
Winner
BCAX
+12.64%
VRDN
-32.09%

BCAX vs VRDN - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

YearBCAXVRDN
2026+77.05%-36.77%
2025-0.56%+57.49%
2024-25.59%-14.23%
2023N/A-23.58%
2022N/A+40.77%
2021N/A+14.94%
2020N/A+115.88%
2019N/A-85.71%
2018N/A-70.61%
2017N/A+102.52%
2016N/A-53.61%
2015N/A-69.47%
2014N/A-72.06%

BCAX vs VRDN Drawdown Comparison

The maximum drawdown for BCAX was -67.82%, occurring on Jun 27, 2025. Recovery took 445 trading sessions.

The maximum drawdown for VRDN was -99.73%, occurring on Mar 19, 2020. This drawdown has not yet recovered.

The current BCAX drawdown is -2.32%. The current VRDN drawdown is -99.05%.

RankBCAXVRDN
#1-67.82%
Sep 17, 2024 - Jun 29, 2026
-99.73%
Jun 18, 2014 - Mar 19, 2020
#2-2.63%
Jun 30, 2026 - Jul 1, 2026
N/A

Correlation

Correlation between BCAX and VRDN is 0.20 which considered as a very weak or no correlation - the stocks move independently of each other.

0.20
-101

Select Stocks to Compare